Granite Investment Partners’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
VPM
VCM
Granite Investment Partners's GH Position: Q1 2026 in Review
Granite Investment Partners reduced its Guardant Health (GH) stake by 39% in Q1 2026, selling an estimated $6.27M and leaving 95,726 shares worth $8.84M. The position accounts for 0.54% of the portfolio, ranked #65.
Granite Investment Partners first reported a position in GH in Q1 2020 and has held it in 17 quarters since. The position peaked at $20.1M in Q2 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- Granite Investment Partners held 95,726 shares of Guardant Health worth $8.84M as of Q1 2026.
- Granite Investment Partners sold 62,473 Guardant Health shares in Q1 2026, an estimated $6.27M.
- Guardant Health made up 0.54% of Granite Investment Partners's portfolio in Q1 2026, its #65 holding.
- Granite Investment Partners first reported a position in Guardant Health in Q1 2020 and has held it in 17 quarters since.
- Granite Investment Partners's Guardant Health position peaked at $20.1M in Q2 2025.
- 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.